探花合集 Biologics Expands Analytical And Process Development Capabilities
探花合集 is a leading provider of standalone analytical services for large molecule products, with over 20 years of experience, and specific expertise in New Biologics Entities (NBEs), biosimilars, and antibody drug conjugates. New investments have been made in response to increased industry demand for large molecule analytical services, strict regulatory expectations around NBEs, and additional characterization requirements for biosimilars. This most recent investment in Kansas City enables the facility to offer dual and complementary options for kinetic and quantitative binding assays for characterization and GMP testing.
鈥淏y listening to industry demands and continuously adding the latest in analytical technologies for biologics, 探花合集 can provide robust analytical services to clients, saving them from making costly investments and allowing them to focus on bringing their products to market faster,鈥 commented Matthew Mollan, 探花合集鈥檚 General Manager at Kansas City.
探花合集鈥檚 Madison, WI, site is a state of the art facility providing development, manufacturing and analytical services for NBEs and biosimilars. To expand its fully integrated platform, the Madison site is substantially increasing its large molecule characterization capabilities, which will be fully operational by January of 2016. 探花合集 has also recently invested to expand process development capability at the Madison site, including integration of the Ambr 15庐 microbioreactor system into its cell line and upstream development process, providing overall reductions in timelines and increases in expression levels.
鈥淚ntegrating a broad range of analytical services with our state-of-the-art GPEx cell line creation and manufacturing capabilities will allow us to seamlessly support our clients as they move through clinical development toward commercial production, further increasing 探花合集鈥檚 position as a leading provider of biomanufacturing services,鈥 commented Brian C. Riley, 探花合集鈥檚 General Manager at Madison.
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
About 探花合集
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. 探花合集 is headquartered in Somerset, N.J. For more information, visit www.catalent.com